申请人:Shimizu Kazuo
公开号:US20110230454A1
公开(公告)日:2011-09-22
The present invention provides compounds useful as agents for the prevention or treatment of a disease associated with abnormal serum uric acid level which has a uricosuric activity or the like. The present invention relates to (aza)indole derivatives represented by the following general formula (I) having xanthine oxidase inhibitory activities and useful as agents for the prevention or treatment of a disease associated with abnormality of serum uric acid level, prodrugs thereof, or salts thereof. In the formula (I), T represents nitro or cyano and the like; ring J represents aryl or heteroaryl and the like; Q represents carboxy or 5-tetazolyl and the like; Y represents H, OH, NH
2
, halogen, nitro, alkyl, alkoxy and the like; X
1
, X
2
and X
3
independently represent CR
2
or N; R
1
and R
2
independently represent halogen, cyano, haloalkyl, A-D-E-G, —N(-D-E-G)
2
and the like, in the formula, A represents a single bond, O, S and the like; D and G independently represent optionally substituted alkylene, cycloalkylene, heterocycloalkylene, arylene, heteroarylene and the like; E represents a single bond, O, S, COO, SO
2
and the like.
本发明提供了一种化合物,其具有
尿酸排泄活性或类似作用,可用作预防或治疗与异常血清
尿酸水平相关的疾病的药剂。本发明涉及以下通式(I)所代表的(氮)
吲哚衍
生物,其具有
黄嘌呤氧化酶抑制活性,并可用作预防或治疗与血清
尿酸水平异常相关的疾病的药剂,其前体药物或盐。在公式(I)中,T代表硝基或
氰基等;环J代表芳基或杂环芳基等;Q代表羧基或5-
四唑基等;Y代表H、OH、NH2、卤素、硝基、烷基、烷氧基等;X1、X2和X3独立地代表CR2或N;R1和R2独立地代表卤素、
氰基、卤代烷基、A-D-E-G、-N(-D-E-G)2等,在公式中,A代表单键,O,S等;D和G独立地代表可选的取代的烷基,环烷基,杂环烷基,芳基,杂环芳基等;E代表单键,O,S,COO,SO2等。